Related Experiment Video
Updated: Jul 14, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
CRISPRi-Mediated Epigenetic Suppression of TERT Reduces Cell Growth in Non-Small-Cell Lung Cancer Cells
Seong-Ho Park1, Juyoung Hong2, Woochang Hwang3,4
1Department of Life Science, College of Natural Sciences, Hanyang University, Seongdong-gu, Seoul 04763, Republic of Korea.
Abstract:
TERT, the catalytic subunit of telomerase, is aberrantly activated in most cancers and represents an attractive therapeutic target. However, conventional TERT-targeting strategies, including chemical inhibitors and siRNA, are limited by several issues, such as insufficient efficacy and off-target effects. In this study, we investigated whether dCas9-KRAB-mediated CRISPR interference (CRISPRi) could overcome the limitations by transcriptional repression of TERT without DNA cleavage. We first assessed the efficacy of the dCas9-KRAB system by applying it to H1299 non-small-cell lung cancer cells and observed reduction in TERT expression up to approximately 80% and significant decreases in cell viability and growth. Transcriptome-wide analysis showed limited detectable changes in non-target-gene expression under the conditions tested. Together, the results suggest that dCas9-KRAB-mediated CRISPRi could serve as a proof-of-principle approach for targeted repression of TERT in cancer cells with limited detectable effects on non-target-gene expression.
Insights
CRISPR interference (CRISPRi) using dCas9-KRAB effectively repressed telomerase reverse transcriptase (TERT) expression in lung cancer cells. This novel approach reduced cancer cell viability and growth with minimal off-target effects, offering a promising therapeutic strategy.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Telomerase reverse transcriptase (TERT) is a key driver in most cancers, making it a significant therapeutic target.
- Existing TERT-targeting methods like chemical inhibitors and siRNA face challenges including limited efficacy and off-target effects.
Purpose of the Study:
- To evaluate the efficacy of dCas9-KRAB-mediated CRISPR interference (CRISPRi) for transcriptional repression of TERT.
- To determine if CRISPRi can overcome limitations of conventional TERT-targeting strategies without causing DNA cleavage.
Main Methods:
- The dCas9-KRAB system was applied to H1299 non-small-cell lung cancer cells.
- TERT expression levels were quantified.
- Cell viability and growth were assessed.
- Transcriptome-wide analysis was performed to detect off-target gene expression changes.
Main Results:
- TERT expression was reduced by approximately 80% in treated cells.
- Significant decreases in cancer cell viability and growth were observed.
- Transcriptome-wide analysis revealed limited detectable changes in non-target gene expression.
Conclusions:
- dCas9-KRAB-mediated CRISPRi demonstrates proof-of-principle for targeted TERT repression in cancer cells.
- This method offers a potential strategy for cancer therapy with reduced off-target effects on gene expression.
Related Concept Videos
Replicative Cell Senescence
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
